Bank of New York Mellon’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$424K Buy
375,037
+43,845
+13% +$49.5K ﹤0.01% 3583
2025
Q1
$484K Buy
331,192
+423
+0.1% +$618 ﹤0.01% 3441
2024
Q4
$705K Buy
330,769
+13,150
+4% +$28K ﹤0.01% 3324
2024
Q3
$889K Sell
317,619
-44,745
-12% -$125K ﹤0.01% 3196
2024
Q2
$844K Buy
362,364
+61,811
+21% +$144K ﹤0.01% 3286
2024
Q1
$1.34M Sell
300,553
-23,428
-7% -$105K ﹤0.01% 2988
2023
Q4
$1.04M Buy
323,981
+13,167
+4% +$42.3K ﹤0.01% 3163
2023
Q3
$985K Buy
310,814
+1,928
+0.6% +$6.11K ﹤0.01% 3153
2023
Q2
$1.54M Sell
308,886
-41,283
-12% -$205K ﹤0.01% 2972
2023
Q1
$1.73M Buy
350,169
+41,747
+14% +$206K ﹤0.01% 2879
2022
Q4
$1.94M Buy
308,422
+19,900
+7% +$125K ﹤0.01% 2867
2022
Q3
$3.12M Buy
288,522
+40,141
+16% +$433K ﹤0.01% 2563
2022
Q2
$2.83M Sell
248,381
-50,866
-17% -$580K ﹤0.01% 2639
2022
Q1
$2.73M Buy
299,247
+569
+0.2% +$5.18K ﹤0.01% 2766
2021
Q4
$4.46M Sell
298,678
-20,127
-6% -$300K ﹤0.01% 2523
2021
Q3
$8.19M Buy
318,805
+36,468
+13% +$937K ﹤0.01% 2230
2021
Q2
$7.36M Buy
282,337
+60,187
+27% +$1.57M ﹤0.01% 2290
2021
Q1
$7.84M Sell
222,150
-8,016
-3% -$283K ﹤0.01% 2228
2020
Q4
$5.81M Buy
230,166
+6,947
+3% +$175K ﹤0.01% 2292
2020
Q3
$8.42M Sell
223,219
-5,110
-2% -$193K ﹤0.01% 1946
2020
Q2
$9.78M Buy
228,329
+69,663
+44% +$2.98M ﹤0.01% 1851
2020
Q1
$3.08M Buy
158,666
+2,076
+1% +$40.4K ﹤0.01% 2313
2019
Q4
$4.07M Buy
156,590
+8,801
+6% +$229K ﹤0.01% 2436
2019
Q3
$4.03M Buy
147,789
+13,979
+10% +$381K ﹤0.01% 2388
2019
Q2
$3.59M Buy
133,810
+55,743
+71% +$1.5M ﹤0.01% 2494
2019
Q1
$2.26M Buy
78,067
+43,099
+123% +$1.25M ﹤0.01% 2715
2018
Q4
$941K Buy
+34,968
New +$941K ﹤0.01% 3137